Adma Biologics | ADMA - Assets

Stock Price
15.84
Daily Change
0.69 4.55%
Monthly
-0.69%
Yearly
-15.16%
Q1 Forecast
14.69

Adma Biologics reported $568.69M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Adma Biologics USD 568.69M 10.31M Sep/2025
Alnylam Pharmaceuticals USD 4.97B 114.67M Dec/2025
BioCryst Pharmaceuticals USD 514.16M 67.73M Dec/2025
Minerva Neurosciences USD 97.97M 69.88M Dec/2025
Novavax USD 1.18B 3.38M Dec/2025
Omeros USD 200.57M 34.59M Jun/2025
Takeda JPY 15.41T 938.47B Dec/2025